Nobilis Ma5 + CLONE 30
Nobilis Ma5 + CLONE 30
Authorised
- Newcastle disease virus, strain Clone 30, Live
- Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Product identification
Medicine name:
Nobilis Ma5 + CLONE 30
Active substance:
- Newcastle disease virus, strain Clone 30, Live
- Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
-
Chicken
-
Chicken (chick)
Route of administration:
-
Nebulisation use
-
Oculonasal use
Product details
Active substance and strength:
-
Newcastle disease virus, strain Clone 30, Live6.00log 10 50% embryo infective dose1.00Dose
-
Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live4.00log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
-
Nebulisation use
-
Chicken
-
Egg0day
-
Meat and offal0day
-
-
Chicken (chick)
-
Meat and offal0day
-
Egg0day
-
-
-
Oculonasal use
-
Chicken
-
Egg0day
-
Meat and offal0day
-
-
Chicken (chick)
-
Meat and offal0day
-
Egg0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 190a/92
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 5/04/2022
How useful was this page?: